Immunovia AB (publ) (STO:IMMNOV)
Sweden · Delayed Price · Currency is SEK 0.1622
+0.0006 (0.37%)
Aug 12, 2026, 4:55 PM CET
Immunovia AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.29 | 0.75 | 1.69 | 1.8 | 1.2 | 0.96 | |
Revenue Growth | 15.66% | -55.61% | -5.99% | 49.67% | 25.94% | -3.04% |
Cost of Revenue | 0.52 | 0.14 | 0 | 6.68 | 4.21 | 3.53 |
Gross Profit | 0.76 | 0.62 | 1.69 | -4.88 | -3.01 | -2.58 |
Selling, General & Admin | 80.7 | 77.73 | 94.48 | 148.3 | 162.97 | 162.09 |
Depreciation & Amortization Expenses | 1.88 | 2.33 | 13.42 | 141.72 | 24.91 | 19.06 |
Other Operating Expenses | 0.92 | 0.95 | 3.21 | 1.56 | 0.26 | 1.4 |
Total Operating Expenses | 83.5 | 81 | 111.11 | 291.58 | 188.14 | 182.55 |
Operating Income | -82.74 | -80.39 | -109.41 | -296.46 | -191.15 | -166.63 |
Interest Income | 0.55 | 0.54 | 34.73 | 6.28 | 41.26 | 14.46 |
Interest Expense | -6.15 | -66.07 | -1.86 | -19.26 | -18.2 | -3.8 |
Total Non-Operating Income (Expense) | -5.6 | -65.53 | 32.87 | -12.98 | 23.06 | 10.66 |
Pretax Income | -71.96 | -145.92 | -76.54 | -309.44 | -168.09 | -155.97 |
Net Income | -88.33 | -145.92 | -76.54 | -309.44 | -168.09 | -155.97 |
Net Income to Common | -88.33 | -145.92 | -76.54 | -309.44 | -168.09 | -155.97 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 469 | 344 | 83 | 39 | 23 | 23 |
Shares Outstanding (Diluted) | 469 | 344 | 83 | 39 | 23 | 23 |
Shares Change | 246.63% | 316.79% | 112.20% | 72.02% | - | 10504.89% |
EPS (Basic) | -10.09 | -0.42 | -0.93 | -7.95 | -7.43 | -6.89 |
EPS (Diluted) | -10.09 | -0.42 | -0.93 | -7.95 | -7.43 | -6.89 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -77.35 | -78.4 | -96.75 | -147.06 | -176.84 | -155.75 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.16 | -0.23 | -1.17 | -3.78 | -7.81 | -6.88 |
Gross Margin | 59.46% | 81.91% | 100.00% | -270.81% | -249.75% | -269.56% |
Operating Margin | -6438.83% | -10689.50% | -6458.74% | -16451.70% | -15876.20% | -17429.70% |
Profit Margin | -6874.24% | -19403.60% | -4518.36% | -17172.00% | -13961.10% | -16314.40% |
FCF Margin | -6019.53% | -10425.50% | -5711.51% | -8160.77% | -14687.50% | -16291.70% |
EBITDA | -82.74 | -80.39 | -109.41 | -296.46 | -191.15 | -166.63 |
EBIT | -82.74 | -80.39 | -109.41 | -296.46 | -191.15 | -166.63 |
EBIT Margin | -6438.83% | -10689.50% | -6458.74% | -16451.70% | -15876.20% | -17429.70% |